|
- PrEPX: Rapid scale-up of HIV pre-exposure prophylaxis (PrEP)
Preceding the anticipated public subsidisation of PrEP through Medicare, the Victorian government has funded a program (PrEPX) to rapidly scale‐up PrEP access to GBM through high‐caseload clinics
- PrEP clinics | Alfred Health
PrEP nurses run clinics on Monday and Tuesday and Friday each week A sexual health specialist has a Wednesday clinic each week This clinic is only available to people with Medicare or visitors from countries with reciprocal healthcare agreements You do not need a referral for this clinic
- PrepX - Your AI Study Buddy
PrepX is an AI-powered platform for practicing English tests like PTE, IELTS, and more Improve your skills with personalized exercises, instant feedback, and comprehensive study resources
- PrepX
Forgot Password?
- Pre-exposure prophylaxis - HIV Management Guidelines
WHO defines pre-exposure prophylaxis (PrEP) as the use of oral tenofovir disoproxil fumarate (TDF) or co-formulated TDF emtricitabine (TDF FTC) or co-formulated TDF lamivudine (TDF 3TC) by HIV-negative people to prevent HIV acquisition (FTC and 3TC are considered interchangeable)
- Protocol for an HIV Pre-exposure Prophylaxis (PrEP) Population Level . . .
We describe a study protocol that aims to demonstrate if the provision of PrEP to up to 3800 individuals at risk of HIV in Victoria, Australia reduces HIV incidence locally by 25% generally and 30% among GBM
- Factors influencing coverage of HIV pre-exposure prophylaxis (PrEP) in . . .
Australia is considered to be a leading country in the provision of PrEP to populations at risk of HIV infection The current national HIV strategy includes an aim of increasing to 75% the proportion of eligible people who are on PrEP
- The PrEPX Study - Monash University
The PrEPX Study enrolled over 5,000 participants between 2016 and 2018 in Victoria, South Australia and Tasmania Participants were at risk of HIV infections and received daily tenofovir+ emtricitabine for HIV pre-exposure prophylaxis (PrEP)
|
|
|